Global Xenon-133 Emission Inventory Caused by Medical Isotope Production and Derived from the Worldwide Technetium-99m Demand

Emissions from medical isotope production are the most important source of background for atmospheric radioxenon measurements, which are an essential part of nuclear explosion monitoring. This article presents a new approach for estimating the global annual radioxenon emission inventory caused by me...

Full description

Saved in:
Bibliographic Details
Published in:Pure and applied geophysics 2014-03, Vol.171 (3-5), p.707-716
Main Authors: Kalinowski, Martin B., Grosch, Martina, Hebel, Simon
Format: Article
Language:English
Subjects:
Atmosphere
Atmospherics
Demand
Earth and Environmental Science
Earth Sciences
Emission
Emission inventories
Emissions
Estimating
Geophysics/Geodesy
Inventories
Isotopes
Medical
Medical treatment
Radiology
Stockpiling
Technetium
Xenon
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Emissions from medical isotope production are the most important source of background for atmospheric radioxenon measurements, which are an essential part of nuclear explosion monitoring. This article presents a new approach for estimating the global annual radioxenon emission inventory caused by medical isotope production using the amount of Tc-99m applications in hospitals as the basis. Tc-99m is the most commonly used isotope in radiology and dominates the medical isotope production. This paper presents the first estimate of the global production of Tc-99m. Depending on the production and transport scenario, global xenon emissions of 11–45 PBq/year can be derived from the global isotope demand. The lower end of this estimate is in good agreement with other estimations which are making use of reported releases and realistic process simulations. This proves the validity of the complementary assessment method proposed in this paper. It may be of relevance for future emission scenarios and for estimating the contribution to the global source term from countries and operators that do not make sufficient radioxenon release information available. It depends on sound data on medical treatments with radio-pharmaceuticals and on technical information on the production process of the supplier. This might help in understanding the apparent underestimation of the global emission inventory that has been found by atmospheric transport modelling.
ISSN:0033-4553
1420-9136
DOI:10.1007/s00024-013-0687-5